Showing 1281-1290 of 1690 results for "".
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31356/Practical Neurology January 2006 SummaryThe January 2006 issue of *Practical Neurology* highlights significant advancements and challenges within the neurology field, providing valuable insights for healthcare professionals.Subspecialization in Neurology As neuroscience becomes increasingly intrica
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31390/New AAN Guidelines Enhance Carotid Artery Stenosis ManagementThe American Academy of Neurology (AAN) recently published updated guidelines in *Neurology* (2005;65:794-80) addressing the surgical management of carotid artery stenosis. Synthesizing data from multiple trials between 1990 and 2001, the
Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.Calcitonin Gene-Related Peptide, Monoclonal Antibodies, and Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/calcitonin-gene-related-peptide-monoclonal-antibodies-and-migraine/30404/The recent development of monoclonal antibodies for the treatment of migraine may have a significant impact on the field and mark a new chapter in patient care.Normal Pressure Hydrocephalus
https://practicalneurology.com/diseases-diagnoses/child-neurology/normal-pressure-hydrocephalus/30200/A treatable cause of dementia.Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.The Prevalence of Migraine and Other Neurological Conditions Among Retired National Football League Players: A Pilot Study
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-prevalence-of-migraine-and-other-neurological-conditions-among-retired-national-football-league-players-a-pilot-study/30304/Findings suggest that retired NFL players may be at increased risk for migraine, depression, anxiety, chronic pain, bedwetting, essential tremor, and Parkinson's disease.Dementia Insights: Cognitive Impairment In Primary Psychiatric Disorders: Role In The Diagnosis Of Cognitive Disorders In Clinical Neurology
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-cognitive-impairment-in-primary-psychiatric-disorders-role-in-the-diagnosis-of-cognitive-disorders-in-clinical-neurology/30746/How does the presence of an ongoing primary psychiatric disorder with or without pharmacotherapy play a role in our aging population who present to the neurologist with symptoms of memory loss and cognitive decline?Novel Treatments for Alzheimer Disease Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/novel-treatments-for-alzheimer-disease-disorders/31801/A selection of drugs currently in clinical trials organized by Common Alzheimer Disease Research Ontology focused on mechanisms of action.Ketamine for Intractable Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/ketamine-for-intractable-headache/31952/For individuals with intractable headache, ketamine may provide acute and longer-term relief.